Jackson Thornton Asset Management, LLC Abb Vie Inc. Transaction History
Jackson Thornton Asset Management, LLC
- $789 Million
- Q1 2025
A detailed history of Jackson Thornton Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson Thornton Asset Management, LLC holds 1,373 shares of ABBV stock, worth $269,204. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,373
Previous 1,200
14.42%
Holding current value
$269,204
Previous $213,000
34.74%
% of portfolio
0.04%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
4,205Shares Held
1.29BCall Options Held
17MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$33.9 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.6 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.78 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $347B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...